★研盟生物 ★合作: ★客服
相關(guān)標(biāo)記抗體:HRP標(biāo)記抗體,Biotin標(biāo)記抗體,Gold標(biāo)記抗體,RBITC標(biāo)記抗體,AP標(biāo)記抗體,FITC標(biāo)記抗體,Cy3標(biāo)記抗體,Cy5標(biāo)記抗體,Cy5.5標(biāo)記抗體,Cy7標(biāo)記抗體,PE標(biāo)記抗體,PE-Cy3標(biāo)記抗體,PE-Cy5標(biāo)記抗體,PE-Cy5.5標(biāo)記抗體,PE-Cy7標(biāo)記抗體,APC標(biāo)記抗體,Alexa Fluor 350標(biāo)記抗體,Alexa Fluor 488標(biāo)記抗體,Alexa Fluor 555標(biāo)記抗體,Alexa Fluor 647標(biāo)記抗體
上海研盟生物科技有限公司Anti-BRI3BP抗體*,主要應(yīng)用于WB、IHC、IF、ELISA、流式細(xì)胞術(shù)等實(shí)驗(yàn)中。說明書隨貨發(fā)送,您也可以直接我司在線客服索取??头?/span>
英文名稱:Anti-BRI3BP antibody
中文名稱:宮jing癌原基因1/bri3結(jié)合蛋白抗體
宮jing癌原基因1抗體保存條件:Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
宮jing癌原基因1/bri3結(jié)合蛋白抗體,Anti-BRI3BP抗體免疫應(yīng)答過程:
1.抗原進(jìn)入機(jī)體;
2.抗原刺激 B淋巴細(xì)胞,使之分化增殖成為抗體分泌漿細(xì)胞和記憶細(xì)胞(初次免疫應(yīng)答);
3.抗體主要由漿細(xì)胞分泌 ;
4.記憶細(xì)胞再次受到特異性抗原刺激后會(huì)被激活而成為分泌抗體的漿細(xì)胞(再次免疫應(yīng)答);
5.記憶B細(xì)胞是長命細(xì)胞,可以存活數(shù)月甚至機(jī)體終生 。
★研盟生物★宮jing癌原基因1/bri3結(jié)合蛋白抗體,Anti-BRI3BP抗體
Western Blotting 實(shí)驗(yàn)步驟概述
1、 組織取材:組織塊稱重
2、 利用液氮、研缽粉碎組織塊
3、 加入RIPA緩沖液(每克組織3ml RIPA),PMSF(每克組織30μl,10 mg/ml PMSF),
利用Polytron進(jìn)一步勻漿(15,000轉(zhuǎn)/分*1分鐘)維持4℃
4、 加入PMSF(每克組織30μl,10 mg/ml PMSF),冰上孵育30分鐘
5、 移入離心管4℃,約20,000g(約15,000轉(zhuǎn))15分鐘
6、 上清液為細(xì)胞裂解液可分裝-20℃保存
7、 進(jìn)行Bradford比色法測定蛋白質(zhì)濃度
8、 取相同質(zhì)量的細(xì)胞裂解液(體積*蛋白質(zhì)濃度),并加等體積的2×電泳加樣緩沖液
9、 沸水浴中3分鐘
10、上樣
11、電泳(濃縮膠20mA,分離膠35mA)
12、電轉(zhuǎn)膜儀轉(zhuǎn)膜(100mA 40分鐘)
13、膜用麗春紅染色,膠用考馬斯亮藍(lán)染色
14、Westernblot 試劑盒顯色
15、分析比較記錄
簡單介紹:
產(chǎn)品別名:BRI3-binding protein; HCCR-1; HCCR1; HCCRBP-1; I3-binding protein; Cervical cancer 1 proto-oncogene-binding protein KG19; I3-binding protein; BRI3B_HUMAN; BRI3BP.
抗體來源:Rabbit or Mouse
保質(zhì)期:1年
克隆類型:Polyclonal or monoclonal
性 狀:Lyophilized or Liquid
濃 度:1mg/1ml
背景介紹:BRI3BP is a 251 amino acid multi-pass membrane protein. Though widely expressed, BRI3BP is found at highest levels in brain, kidney and liver where it localizes to the endoplasmic reticulum (ER) and is involved in ER structural dynamics and mitochondrial viability. Possessing pro-apoptotic properties and the ability to potentiate drug-induced apoptosis, BRI3BP overexpression has been shown to enhance caspase-3 and mitochondrial cytochrome c release in etoposide-treated human embryonic kidney 293T cells. The gene encoding BRI3BP maps to human chromosome 12, which encodes over 1,100 genes and comprises approximay 4.5% of the human genome. Chromosome 12 is associated with a variety of diseases and afflictions, including hypochondrogenesis, achondrogenesis, Kniest dysplasia, Noonan syndrome and trisomy 12p, which causes facial developmental defects and seizure disorders.
相關(guān)優(yōu)質(zhì)產(chǎn)品:
ERK1/2(Mitogen-activated protein kinase 1/2) 絲裂原活化蛋白激酶1/2抗體
phospho-ERK1/pERK(pThr202/pThr204)+phospho ERK2(pThr183/pTyr185) 抗、大、小鼠磷酸化絲裂原活化蛋白激酶1/2抗體
Eph receptor B2 Eph receptor B2抗體
MAPK1/ERK3 (Mitogen-activated protein kinase 3; P44MAPK) 絲裂原活化蛋白激酶3抗體
MAPK4(Mitogen-activated protein kinase 4) 絲裂原活化蛋白激酶4抗體
MKP-1/DUSP1(Mitogen activated protein kinase phosphatase 1) 絲裂原活化蛋白激酶磷酸酶-1抗體
MKP-2/DUSP4(Mitogen activated protein kinase phosphatase 2) 絲裂原活化蛋白激酶磷酸酶-2抗體
ER-α(Estrpgen Receptor alpha) 雌激素受體α抗體
ER/PR/c-erbB-2 Kit(mouse monoclonal) ER/PR/c-erbB-2優(yōu)質(zhì)產(chǎn)品試劑盒(鼠單抗)
phospho-ER-α(pSer167)human 抗磷酸化雌激素受體α抗體
phospho-ER-α(pTyr537)mouse ret 抗、大、小鼠、牛、犬磷酸化雌激素受體α抗體
ER-α(Estrpgen Receptor alpha) 雌激素受體α抗體(用于westen blot)
ER-α(Estrpgen Receptor alpha) 雌激素受體α抗體
ER-α/β Estrpgen Receptor α/β 雌激素受體α/β抗體